text.skipToContent text.skipToNavigation
Need help? Please contact us

Human CD34+ Progenitor Cells from Mobilized Peripheral Blood, Positive Selection, 10 Million

Catalog #: 2Y-101E

Cryopreserved ampule of Human CD34+ Progenitor Cells from Mobilized Peripheral Blood using positive immunomagnetic selection containing 10 million cells

 8’227.00 CHF

Product Overview

Mobilized peripheral blood CD34+ hematopoietic stem and progenitor cells are positively selected using a immunomagnetic CD34 microbead labeling system. Cells are cryopreserved in Lonza Cryo Media in a cryovial. Cell purity is determined post thaw using a FACS assay. Count and viability is determined using hemacytometer (trypan blue method). Cells are collected from healthy donors following IRB protocols.


  • Obtain large quantities of CD34+ from a mobilized donor
  • Certificate of analysis (CoA) provided for each lot purchased
  • HIV-1, Hepatitis B and Hepatitis C are not detected for all donors and/or cell lots


  • CAR-T therapy development
  • Stem cell physiology
  • iPSC generation
  • Autoimmune disease
  • Immunology
  • Cancer therapy research

Content & Storage


1 x Cryopreserved ampule of Human CD34+ Progenitor Cells from Mobilized Peripheral Blood containing ≥ 10 million cells


Safety Data Sheets (SDS)

Certificate of Analysis (CoA)

Please enter Lot Number, including all zeros, located on the product label and please take into account that it is case sensitive.

Need a Quote or Any Support?

Request a local representative to get back to you with additional information or pricing.

Immunotherapy and Hematopoietic Knowledge Center

The Immunotherapy and Hematopoietic Knowledge Center is dedicated to sharing interesting articles and resources related to immuno and hematopoietic research.

Subscribe to our eNewsletter

Keep up to speed on the latest scientific developments, events, tips and tools from Lonza.